Patients and study design
systemic lupus erythematosus
DISEASE, SYSTEMIC LUPUS ERYTHEMATOSUS
We conducted the study in two phases. Phase I was a cross-sectional study, and phase II was an interventional study. Patients with systemic lupus erythematosus who satisfied the SLICC 2012 classification criteria [The respective institutional ethics committees approved the study, and we conducted the study in accordance with the declaration of Helsinki's guidelines for human research. All patients gave written informed consent.Demographic, anthropometric and socioeconomic (SES) details per modified Kuppuswamy’s classification [Disease activity was assessed using SLE Disease Activity Index-2000 (SLEDAI-2K) [For the interventional study (phase II), SLE patients satisfying the SLICC 2012 classification criteria [Flow diagram elaborating the details of the design and execution of the study